Ítem
Acceso Abierto

Desenlaces inmunológicos de pacientes con cáncer sometidos a diferentes técnicas anéstesicas : revisión de alcance

Mostrar el registro sencillo de la publicación
dc.contributorBarragán, Ana Maria
dc.contributor.advisorOsorio, John Jairo
dc.creatorGuayacán Baquero, Martín Leonardo
dc.creatorFlórez Acevedo, Andrés Felipe
dc.creator.degreeEspecialista en Anestesiología HOKspa
dc.creator.degreetypeFull timespa
dc.date.accessioned2019-07-31T16:59:23Z
dc.date.available2019-07-31T16:59:23Z
dc.date.created2019-07-19
dc.date.issued2019
dc.descriptionEl cáncer es una de las patologías de mayor aumento de morbimortalidad a nivel mundial, siendo el manejo quirúrgico uno de los pilares fundamentales para su tratamiento, en donde el acto anestésico cada vez cobra más relevancia, se ha planteado impacto desde el punto de vista inmunológico y en la recidiva tumoral según el tipo y la técnica anestésica realizada. El objetivo de esta revisión de alcance es proveer un marco sobre el conocimiento disponible alrededor del efecto de las técnicas anestésicas sobre la función inmunológica mediada por CNK e interleucinas de pacientes con cáncer sometidos a tratamiento quirúrgico para el manejo de la patología. Se incluirán todos los diseños epidemiológicos entre los años 2009 a 2019 de pacientes con cáncer en quienes se hayan realizado técnicas anestésicas en procedimientos quirúrgicos y documentado medición de función de sistema inmune según cada técnica anestésica usada. Se encontraron 13 artículos los cuales incluyeron 745 pacientes en diferentes partes del mundo. Midiendo recuento de CNK, recuento de CD4, CD8 y la relación entre CD4/CD8, así como niveles de interleucinas en pacientes sometidos a procedimientos quirúrgicos con técnicas anestésicas general o combinada. Conclusión: Según los resultados de la revisión se encontró que al comparar las técnicas anestésicas general endovenosa vs inhalatoria, no había diferencias significativas a favor de alguna de las dos técnicas. Caso contrario sucedió al comparar anestesia general vs técnica neuroaxial o bloqueo periférico en donde se encontró mayor conteo leucocitario y mayor respuesta inmune en los pacientes llevados a procedimientos quirúrgicos con técnicas regionales.spa
dc.description.abstractCancer is one of the pathologies with the highest increase in morbidity and mortality worldwide, and surgical management is one of the fundamental treatment axes, where the anesthetic act is becoming more and more important, an impact has been raised from the immunological point of view and in tumor recurrence according to the type and anesthetic technique performed. The objective of this scope review is to provide a framework on the available knowledge around the effect of anesthetic techniques on the immune function mediated by CNK and interleukins of cancer patients sometimes surgical treatment for the management of pathology. All epidemiological designs between 2009 and 2019 of cancer patients who have performed anesthetic techniques in surgical and documented procedures will be included. According to each anesthetic technique used. 13 Articles were found which included 745 patients in different contradictory of the world. Measuring CNK count, CD4 count, CD8 and the ratio between CD4 / CD8, as well as interleukin levels in patients undergoing procedures Surgeries with general or combined anesthetic techniques. Conclusion: according to the results of the review intravenous vs inhalation general anesthetic techniques, there were no differences. It means a favor of one of the two techniques. Otherwise, it happened when comparing general anesthesia vs neuroaxial technique or peripheral block where there is a greater leukocyte count and a greater response. Surgical procedures with regional techniques. eng
dc.format.mimetypeapplication/pdf
dc.identifier.doihttps://doi.org/10.48713/10336_20024
dc.identifier.urihttp://repository.urosario.edu.co/handle/10336/20024
dc.language.isospa
dc.publisherUniversidad del Rosariospa
dc.publisher.departmentFacultad de Medicinaspa
dc.publisher.programEspecialización en Anestesiología HOKspa
dc.rightsAtribución-NoComercial-SinDerivadas 2.5 Colombiaspa
dc.rights.accesRightsinfo:eu-repo/semantics/openAccess
dc.rights.accesoAbierto (Texto Completo)spa
dc.rights.licenciaEL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización. -------------------------------------- POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación podré solicitar la consulta, corrección y supresión de mis datos.spa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.source.bibliographicCitationKurosawa S. Anesthesia in patients with cancer disorders. Curr Opin Anaesthesiol. 2012;25(3):376-384. doi:10.1097/ACO.0b013e328352b4a8spa
dc.source.bibliographicCitationByrne K, Levins KJ, Buggy DJ. Les techniques d’anesthésie et d’analgésie lors d’une chirurgie de cancer primitif peuvent-elle affecter la récurrence ou la métastase? Can J Anesth. 2016;63(2):184-192. doi:10.1007/s12630-015-0523-8spa
dc.source.bibliographicCitationShapiro J, Jersky J, Katzav S. Anesthetic drugs accelerate the progression of postoperative metastases of mouse tumors. J Clin Invest. 1981;68(3):678-685. doi:10.1172/JCI110303spa
dc.source.bibliographicCitationPuig N, Colluci D, Hernandez-Pando R. Influence of anaesthetic drugs on immune response: from inflammation to immunosuppression. OA Anaesth. 2013;1(3):21. https://www.oapublishinglondon.com/article/1091.spa
dc.source.bibliographicCitationMelamed R, Bar-Yosef S, Shakhar G, Shakhar K, Ben-Eliyahu S. Suppression of Natural Killer Cell Activity and Promotion of Tumor Metastasis by Ketamine, Thiopental, and Halothane, but Not by Propofol: Mediating Mechanisms and Prophylactic Measures. Anesth Analg. 2003;97(5):1331-1339. doi:10.1213/01.ANE.0000082995.44040.07spa
dc.source.bibliographicCitationCho JS, Lee M-H, Kim S Il, et al. The Effects of Perioperative Anesthesia and Analgesia on Immune Function in Patients Undergoing Breast Cancer Resection: A Prospective Randomized Study. Int J Med Sci. 2017;14(10):970-976. doi:10.7150/ijms.20064spa
dc.source.bibliographicCitationAl-Hasani R, Bruchas MR. Molecular Mechanisms of Opioid Receptor-Dependent Signalling and Behaviour. Anesthesiology. 2011;115(6):1363-1381. doi:10.1097/ALN.0b013e318238bba6.Molecularspa
dc.source.bibliographicCitationChen WK, Ren L, Wei Y, Zhu DX, Miao CH, Xu JM. General anesthesia combined with epidural anesthesia ameliorates the effect of fast-track surgery by mitigating immunosuppression and facilitating intestinal functional recovery in colon cancer patients. Int J Colorectal Dis. 2015;30(4):475-481. doi:10.1007/s00384-014-2098-1spa
dc.source.bibliographicCitationBorner C, Warnick B, Smida M, et al. Mechanisms of Opioid-Mediated Inhibition of Human T Cell Receptor Signaling. J Immunol. 2009;183(2):882-889. doi:10.4049/jimmunol.0802763spa
dc.source.bibliographicCitationWang J, Barke RA, Charboneau R, Loh HH, Roy S. Morphine negatively regulates interferon-γ promoter activity in activated murine T cells through two distinct cyclic AMP-dependent pathways. J Biol Chem. 2003;278(39):37622-37631. doi:10.1074/jbc.M301224200spa
dc.source.bibliographicCitationKurosawa S, Kato M. Anesthetics, immune cells, and immune responses. J Anesth. 2008;22(3):263-277. doi:10.1007/s00540-008-0626-2spa
dc.source.bibliographicCitationZhou Y, Li E, Li Y, Liu S. Attenuating sevoflurane-induced cellular injury of human peripheral lymphocytes by propofol in a concentration-dependent manner. Arch Pharm Res. 2011;34(9):1535-1543. doi:10.1007/s12272-011- 0916-3spa
dc.source.bibliographicCitationWei H, Xie Z. Anesthesia, calcium homeostasis and Alzheimer’s disease. Curr Alzheimer Res. 2009;6(1):30-35. doi:10.2174/156720509787313934spa
dc.source.bibliographicCitationBraz MG, Magalhães MR, Salvadori DM, et al. Evaluation of DNA damage and lipoperoxidation of propofol in patients undergoing elective surgery. Eur J Anaesthesiol. 2009;26(8):654-660. doi:10.1097/EJA.0b013e328329b12cspa
dc.source.bibliographicCitationRizzo MT. Cyclooxygenase-2 in oncogenesis. Clin Chim Acta. 2011;412(9- 10):671-687. doi:10.1016/j.cca.2010.12.026spa
dc.source.bibliographicCitationKushida A, Inada T, Shingu K. Enhancement of antitumor immunity after propofol treatment in mice. Immunopharmacol Immunotoxicol. 2007;29(3- 4):477-486. doi:10.1080/08923970701675085spa
dc.source.bibliographicCitationPirbudak Cocelli L, Ugur MG, Karadasli H. Comparison of Effects of Low-Flow Sevoflurane and Desflurane Anesthesia on Neutrophil and T-Cell Populations. Curr Ther Res - Clin Exp. 2012;73(1-2):41-51. doi:10.1016/j.curtheres.2012.02.005spa
dc.source.bibliographicCitationBenish M, Bartal I, Goldfarb Y, et al. Perioperative use of β-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis. Ann Surg Oncol. 2008;15(7):2042-2052. doi:10.1245/s10434-008- 9890-5spa
dc.source.bibliographicCitationGlasner A, Avraham R, Rosenne E, et al. Improving Survival Rates in Two Models of Spontaneous Postoperative Metastasis in Mice by Combined Administration of a β-Adrenergic Antagonist and a Cyclooxygenase-2 Inhibitor. J Immunol. 2010;184(5):2449-2457. doi:10.4049/jimmunol.0903301spa
dc.source.bibliographicCitationWang X, Liang Y, Wang J, Wang M. Effect of NS-398, a cyclooxygenase-2 selective inhibitor, on the cytotoxicity of cytotoxic T lymphocytes to ovarian carcinoma cells. Tumor Biol. 2013;34(3):1517-1522. doi:10.1007/s13277-013-0677-3spa
dc.source.bibliographicCitationVeltman JD, Lambers MEH, van Nimwegen M, et al. COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function. BMC Cancer. 2010;10:1-13. doi:10.1186/1471-2407-10-464spa
dc.source.bibliographicCitationLönnroth C, Andersson M, Arvidsson A, et al. Preoperative treatment with a non-steroidal anti-inflammatory drug (NSAID) increases tumor tissue infiltration of seemingly activated immune cells in colorectal cancer. Cancer Immun. 2008;8(February):1-10. doi:080206 [pii]spa
dc.source.bibliographicCitationRamirez MF, Tran P, Cata JP. The effect of clinically therapeutic plasma concentrations of lidocaine on natural killer cell cytotoxicity. Reg Anesth Pain Med. 2015;40(1):43-48. doi:10.1097/AAP.0000000000000191spa
dc.source.bibliographicCitationDas J, Kumar S, Khanna S, Mehta Y. Are we causing the recurrence-impact of perioperative period on long-term cancer prognosis: Review of current evidence and practice. J Anaesthesiol Clin Pharmacol. 2014;30(2):153. doi:10.4103/0970-9185.129996spa
dc.source.bibliographicCitationSacerdote P, Bianchi M, Gaspani L, et al. The effects of tramadol and morphine on immune responses and pain after surgery in cancer patients. Anesth Analg. 2000;90(6):1411-1414. doi:10.1097/00000539-200006000-00028spa
dc.source.bibliographicCitationQi Y, Yao X, Zhang B, Du X. Comparison of recovery effect for sufentanil and remifentanil anesthesia with TCI in laparoscopic radical resection during colorectal cancer. Oncol Lett. 2016;11(5):3361-3365. doi:10.3892/ol.2016.4394spa
dc.source.bibliographicCitationLiang H, Yang CX, Zhang B, et al. Sevoflurane suppresses hypoxia-induced growth and metastasis of lung cancer cells via inhibiting hypoxia-inducible factor-1α. J Anesth. 2015;29(6):821-830. doi:10.1007/s00540-015-2035-7spa
dc.source.bibliographicCitationEcimovic P, Mchugh B, Murray D, Doran P, Buggy DJ. Effects of sevoflurane on breast cancer cell function in vitro. Anticancer Res. 2013;33(10):4255-4260. doi:10.1097/00003643-201006121-00001spa
dc.source.bibliographicCitationDeegan CA, Murray D, Doran P, Ecimovic P, Moriarty DC, Buggy DJ. Effect of anaesthetic technique on oestrogen receptor-negative breast cancer cell function in vitro. Br J Anaesth. 2009;103(5):685-690. doi:10.1093/bja/aep261spa
dc.source.bibliographicCitationFerrell JK, Cattano D, Brown RE, Patel CB, Karni RJ. The effects of anesthesia on the morphoproteomic expression of head and neck squamous cell carcinoma: A pilot study. Transl Res. 2015;166(6):674-682. doi:10.1016/j.trsl.2015.09.001spa
dc.source.bibliographicCitationHuang H, Benzonana LL, Zhao H, et al. Prostate cancer cell malignancy via modulation of HIF-1α pathway with isoflurane and propofol alone and in combination. Br J Cancer. 2014;111(7):1338-1349. doi:10.1038/bjc.2014.426spa
dc.source.bibliographicCitationLuo X, Zhao H, Hennah L, et al. Impact of is of lurane on malignant capability of ovarian cancer in vitro. Br J Anaesth. 2015;114(5):831-839. doi:10.1093/bja/aeu408spa
dc.source.bibliographicCitationCaveolins LA, Murray F, Ph D, et al. Volatile Anesthetics Protect Cancer Cells against Tumor Necrosis Factor-related Apoptosis-inducing. 2011;(September).spa
dc.source.bibliographicCitationMoudgil GC, Gordon J, Forrest JB. Comparative effects of volatile anaesthetic agents and nitrous oxide on human leucocyte chemotaxis in vitro. Can Anaesth Soc J. 1984;31(6):631-637. doi:10.1007/BF03008758spa
dc.source.bibliographicCitationHatzoglou A, Bakogeorgou E, Castanas E. The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors. Eur J Pharmacol. 1996;296(2):199-207. doi:10.1016/0014-2999(95)00703-2spa
dc.source.bibliographicCitationTegeder I. Opioids As Modulators of Cell Death and Survival--Unraveling Mechanisms and Revealing New Indications. Pharmacol Rev. 2004;56(3):351- 369. doi:10.1124/pr.56.3.2spa
dc.source.bibliographicCitationLin X, Wang YJ, Li Q, et al. Chronic high-dose morphine treatment promotes SH- SY5Y cell apoptosis via c-Jun N-terminal kinase-mediated activation of mitochondria-dependent pathway. FEBS J. 2009;276(7):2022-2036. doi:10.1111/j.1742-4658.2009.06938.xspa
dc.source.bibliographicCitationTegeder I, Grösch S, Schmidtko A, et al. G protein-independent G1 cell cycle block and apoptosis with morphine in adenocarcinoma cells: Involvement of p53 phosphorylation. Cancer Res. 2003;63(8):1846-1852.spa
dc.source.bibliographicCitationGach K, Szemraj J, Wyrȩbska A, Janecka A. The influence of opioids on matrix metalloproteinase-2 and -9 secretion and mRNA levels in MCF-7 breast cancer cell line. Mol Biol Rep. 2011;38(2):1231-1236. doi:10.1007/s11033-010-0222-zspa
dc.source.bibliographicCitationSingleton PA, Mirzapoiazova T, Hasina R, Salgia R, Moss J. Increased μ-opioid receptor expression in metastatic lung cancer. Br J Anaesth. 2014;113(SUPPL. 1):1-6. doi:10.1093/bja/aeu165spa
dc.source.bibliographicCitationLennon Frances E. PD, Mirzapoiazova Ph.D. , Tamara MD, Mambetsariev Bolot PD, Salgia Ph.D. , Ravi MD, Moss Ph.D. , Jonathan MD, Singleton Patrick A. PD. Overexpression of the μ-Opioid Receptor in Human Non-Small Cell Lung Cancer Promotes Akt and mTOR Activation, Tumor Growth, and Metastasis. Anesthesiology. 2012;116(4):857-867. http://dx.doi.org/10.1097/ALN.0b013e31824babe2.spa
dc.source.bibliographicCitationMathew B, Lennon FE, Siegler J, et al. The novel role of the mu opioid receptor in lung cancer progression: A laboratory investigation. Anesth Analg. 2011;112(3):558-567. doi:10.1213/ANE.0b013e31820568afspa
dc.source.bibliographicCitationLennon FE, Mirzapoiazova T, Mambetsariev B, et al. The Mu opioid receptor promotes opioid and growth factor-induced proliferation, migration and Epithelial Mesenchymal Transition (EMT) in human lung cancer. PLoS One. 2014;9(3):1-13. doi:10.1371/journal.pone.0091577spa
dc.source.bibliographicCitationSingleton PA, Lingen MW, Fekete MJ, Garcia JGN, Moss J. Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: Role of receptor transactivation. Microvasc Res. 2006;72(1-2):3-11. doi:10.1016/j.mvr.2006.04.004spa
dc.source.bibliographicCitationSingleton PA, Moss J. Cancer Recurrence : a Hypothesis. 2010:1237-1242spa
dc.source.bibliographicCitationGupta K, Kshirsagar S, Chang L, et al. Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Res. 2002;62(15):4491-4498spa
dc.source.bibliographicCitationBimonte S, Barbieri A, Rea D, et al. Morphine Promotes Tumor Angiogenesis and Increases Breast Cancer Progression. Biomed Res Int. 2015;2015. doi:10.1155/2015/161508spa
dc.source.bibliographicCitationLeo S, Nuydens R, Meert TF. Opioid-induced proliferation of vascular endothelial cells. J Pain Res. 2009;2:59-66. doi:10.1300/J426v02n04spa
dc.source.bibliographicCitationPage GG, Ben-Eliyahu S, Yirmiya R, Liebeskind JC. Morphine attenuates surgeryinduced enhancement of metastatic colonization in rats. Pain. 1993;54(1):21- 28. doi:10.1016/0304-3959(93)90095-7spa
dc.source.bibliographicCitationPage GG, Mcdonald JS, Ben-Eliyahu S. Pre-operative versus postoperative administration of morphine: Impact on the neuroendocrine, behavioural, and metastatic-enhancing effects of surgery. Br J Anaesth. 1998;81(2):216-223. doi:10.1093/bja/81.2.216spa
dc.source.bibliographicCitationCata JP, Keerty V, Keerty D, et al. A retrospective analysis of the effect of intraoperative opioid dose on cancer recurrence after non-small cell lung cancer resection. Cancer Med. 2014;3(4):900-908. doi:10.1002/cam4.236spa
dc.source.bibliographicCitationLi AX, Xin WQ, Ma CG. Fentanyl inhibits the invasion and migration of colorectal cancer cells via inhibiting the negative regulation of Ets-1 on BANCR. Biochem Biophys Res Commun. 2015;465(3):594-600. doi:10.1016/j.bbrc.2015.08.068spa
dc.source.bibliographicCitationZhang XL, Chen ML, Zhou SL. Fentanyl inhibits proliferation and invasion of colorectal cancer via β-catenin. Int J Clin Exp Pathol. 2015;8(1):227-235.spa
dc.source.bibliographicCitationBundscherer A, Malsy M, Gebhardt K, et al. Effects of ropivacaine, bupivacaine and sufentanil in colon and pancreatic cancer cells in vitro. Pharmacol Res. 2015;95-96:126-131. doi:10.1016/j.phrs.2015.03.017spa
dc.source.bibliographicCitationJuneja R. Opioids and cancer recurrence. Curr Opin Support Palliat Care. 2014;8(2):91-101. doi:10.1097/SPC.0000000000000056spa
dc.source.bibliographicCitationXu L, Stevens J, Hilton MB, et al. COX-2 inhibition potentiates antiangiogenic cancer therapy and prevents metastasis in preclinical models. Sci Transl Med. 2014;6(242). doi:10.1126/scitranslmed.3008455spa
dc.source.bibliographicCitationHarris RE, Beebe-Donk J, Alshafie GA. Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors. BMC Cancer. 2006;6:1- 5. doi:10.1186/1471-2407-6-27spa
dc.source.bibliographicCitationRetsky M, Rogers R, Demicheli R, et al. NSAID analgesic ketorolac used perioperatively may suppress early breast cancer relapse: Particular relevance to triple negative subgroup. Breast Cancer Res Treat. 2012;134(2):881-888. doi:10.1007/s10549-012-2094-5spa
dc.source.bibliographicCitationTseng JH, Cowan RA, Afonso AM, et al. Gynecologic Oncology Perioperative epidural use and survival outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer. Gynecol Oncol. 2018;151(2):287-293. doi:10.1016/j.ygyno.2018.08.024spa
dc.source.bibliographicCitationSoltanizadeh S, Degett TH, Gögenur I. Journal of Clinical Anesthesia Outcomes of cancer surgery after inhalational and intravenous anesthesia : A systematic review. J Clin Anesth. 2017;42:19-25. doi:10.1016/j.jclinane.2017.08.001spa
dc.source.bibliographicCitationCorcoran T, Paech M, Law D, Muchatuta NA, French M, Ho KM. Intraoperative dexamethasone alters immune cell populations in patients undergoing elective laparoscopic gynaecological surgery. Br J Anaesth. 2017;119(2):221-230. doi:10.1093/bja/aex154spa
dc.source.bibliographicCitationHiller JG, Ismail HM, Hofman MS, Narayan K, Ramdave S, Riedel BJ. Neuraxial Anesthesia Reduces Lymphatic Flow. Anesth Analg. 2016;123(5):1325-1327. doi:10.1213/ane.0000000000001562spa
dc.source.bibliographicCitationKim SY, Kim NK, Baik SH, et al. Effects of postoperative pain management on immune function after laparoscopic resection of colorectal cancer: A randomized study. Med (United States). 2016;95(19):1-8. doi:10.1097/MD.0000000000003602spa
dc.source.bibliographicCitationZhou L, Li Y, Li X, et al. Propranolol Attenuates Surgical Stress–Induced Elevation of the Regulatory T Cell Response in Patients Undergoing Radical Mastectomy. J Immunol. 2016;196(8):3460-3469. doi:10.4049/jimmunol.1501677spa
dc.source.bibliographicCitationTedore T. Regional anaesthesia and analgesia: Relationship to cancer recurrence and survival. Br J Anaesth. 2015;115:ii34-ii45. doi:10.1093/bja/aev375spa
dc.source.bibliographicCitationBakr MA-E-M, Amr SA-ER, Mohamed SA, et al. Comparison Between the Effects of Intravenous Morphine, Tramadol, and Ketorolac on Stress and Immune Responses in Patients Undergoing Modified Radical Mastectomy. Clin J Pain. 2016;32(10):889-897. doi:10.1097/AJP.0000000000000338spa
dc.source.bibliographicCitationHeaney Á, Buggy DJ. Can anaesthetic and analgesic techniques affect cancer recurrence or metastasis? Br J Anaesth. 2012;109(SUPPL1):17-28. doi:10.1093/bja/aes421spa
dc.source.bibliographicCitationConrick-Martin I, Kell MR, Buggy DJ. Meta-analysis of the effect of central neuraxial regional anesthesia compared with general anesthesia on postoperative natural killer T lymphocyte function. J Clin Anesth. 2012;24(1):3- 7. doi:10.1016/j.jclinane.2011.09.001spa
dc.source.bibliographicCitationGottschalk A, Brodner G, Van Aken HK, Ellger B, Althaus S, Schulze HJ. Can regional anaesthesia for lymph-node dissection improve the prognosis in malignant melanoma? Br J Anaesth. 2012;109(2):253-259. doi:10.1093/bja/aes176spa
dc.source.bibliographicCitationPapadima A, Boutsikou M, Lagoudianakis EE, et al. Lymphocyte apoptosis after major abdominal surgery is not influenced by anesthetic technique: a comparative study of general anesthesia versus combined general and epidural analgesia. J Clin Anesth. 2009;21(6):414-421. doi:10.1016/j.jclinane.2008.10.015spa
dc.source.bibliographicCitationLim J, Oh C, Yoon T, et al. The effect of propofol and sevoflurane on cancer cell , natural killer cell , and cytotoxic T lymphocyte function in patients undergoing breast cancer surgery : an in vitro analysis. 2018:1-8.spa
dc.source.bibliographicCitationLiu S, Gu X, Zhu L, et al. Effects of propofol and sevoflurane on perioperative immune response in patients undergoing laparoscopic radical hysterectomy for cervical cancer. Medicine (Baltimore). 2016;95(49):e5479. doi:10.1097/MD.0000000000005479spa
dc.source.bibliographicCitationWoo JH, Baik HJ, Kim CH, et al. Effect of Propofol and Desflurane on Immune Cell Populations in Breast Cancer Patients: A Randomized Trial. @BULLET J Korean Med Sci. 2015;30(19):1503-1508. doi:10.3346/jkms.2015.30.10.1503spa
dc.source.bibliographicCitationRen XF, Li WZ, Meng FY, Lin CF. Differential effects of propofol and isoflurane on the activation of T-helper cells in lung cancer patients. 2010:478-482. doi:10.1111/j.1365-2044.2010.06304.xspa
dc.source.bibliographicCitationHan X, Wen X, Li Y, et al. Effect of different anesthetic methods on cellular immune functioning and the prognosis of patients with ovarian cancer undergoing oophorectomy. 2017;0:1-11.spa
dc.source.bibliographicCitationXu Q, Shi N, Zhang H, Zhu Y. Effects of combined general-epidural anesthesia and total intravenous anesthesia on cellular immunity and prognosis in patients with nonsmall cell lung cancer: A comparative study. Mol Med Rep. 2017;(21):4445-4454. doi:10.3892/mmr.2017.714spa
dc.source.bibliographicCitationDesmond F, Mccormack J, Mulligan N, Stokes M, Buggy DJ. Effect of Anaesthetic Technique on Immune Cell Infiltration in Breast Cancer : A Follow-up Pilot Analysis of a Prospective , Randomised , Investigator-masked Study. 2015;1320:1311-1319.spa
dc.source.bibliographicCitationBuckley A, McQuaid S, Johnson P, Buggy DJ. Effect of anaesthetic technique on the natural killer cell anti-tumour activity of serum from women undergoing breast cancer surgery: A pilot study. Br J Anaesth. 2014;113(SUPPL. 1):i56-i62. doi:10.1093/bja/aeu200spa
dc.source.bibliographicCitationXu YJ, Chen WK, Zhu Y, Wang SL, Miao CH. Effect of thoracic epidural anaesthesia on serum vascular endothelial growth factor C and cytokines in patients undergoing anaesthesia and surgery for colon cancer. 2014;113(June):49-55. doi:10.1093/bja/aeu148spa
dc.source.bibliographicCitationCata JP, Gottumukkala V, Thakar D, Keerty D, Gebhardt R, Liu DD. Effects of postoperative epidural analgesia on recurrence-free and overall survival in patients with nonsmall cell lung cancer. J Clin Anesth. 2014;26(1):3-17. doi:10.1016/j.jclinane.2013.06.007spa
dc.source.bibliographicCitationZhou D, Gu F, Gao Q, Li Q, Zhou J, Miao C. Effects of anesthetic methods on preserving anti-tumor T-helper polarization following hepatectomy. 2012;18(24):3089-3098. doi:10.3748/wjg.v18.24.3089spa
dc.source.instnameinstname:Universidad del Rosariospa
dc.source.reponamereponame:Repositorio Institucional EdocURspa
dc.subjectAnestesiaspa
dc.subjectCáncerspa
dc.subjectSistema inmunespa
dc.subject.ddcEnfermedadesspa
dc.subject.keywordAnesthesiaspa
dc.subject.keywordNatural killerspa
dc.subject.keywordCancerspa
dc.subject.keywordImmune systemspa
dc.subject.keywordCellsspa
dc.subject.lembCáncerspa
dc.subject.lembAnestesiaspa
dc.subject.lembAnestésicosspa
dc.titleDesenlaces inmunológicos de pacientes con cáncer sometidos a diferentes técnicas anéstesicas : revisión de alcancespa
dc.typemasterThesiseng
dc.type.documentAnálisis de casospa
dc.type.hasVersioninfo:eu-repo/semantics/acceptedVersion
dc.type.spaTrabajo de gradospa
Archivos
Bloque original
Mostrando1 - 2 de 2
Miniatura
Nombre:
DESENLACES-INMUNOLOGICOS-DE-PACIENTES-CON-CANCER-SOMETIDOS-A-DIFERENTES-TeCNICAS-ANeSTESICAS--REVISION-DE-ALCANCE.2.pdf
Tamaño:
570 KB
Formato:
Adobe Portable Document Format
Descripción:
anexos
Descargar
Miniatura
Nombre:
DESENLACES-INMUNOLOGICOS-DE-PACIENTES-CON-CANCER-SOMETIDOS-A-DIFERENTES-TeCNICAS-ANeSTESICAS--REVISION-DE-ALCANCE.pdf
Tamaño:
480.57 KB
Formato:
Adobe Portable Document Format
Descripción:
documento principal
Descargar
Colecciones
Especialización en Anestesiología HOK